Cargando…
Prediction of inhibitory constants of compounds against SARS-CoV 3CLpro enzyme with 2D-QSAR model
Developing broad-spectrum anti-coronavirus drugs is greatly important, since the novel SARS-CoV-2 has rapidly become a threat to the public health and economy worldwide. SARS-CoV 3-chymotrypsin-like protease (3CLpro), as highly conserved in betacoronavirus, is a viable target for anti-SARS drugs. A...
Autor principal: | Yu, Xinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139336/ http://dx.doi.org/10.1016/j.jscs.2021.101262 |
Ejemplares similares
-
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020) -
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022) -
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
por: Rizzuti, Bruno, et al.
Publicado: (2021) -
In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023) -
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
por: Vankadara, Subramanyam, et al.
Publicado: (2021)